Neozyme International, Inc. Announces Large Purchase by U.S. Army in Korea of Its Bio-Organic Catalyst Product

Neozyme International, Inc. Announces Large Purchase by U.S. Army
in Korea of Its Bio-Organic Catalyst Product 


COSTA MESA, Calif., May 11  /PRNewswire-FirstCall/ -- Neozyme International,
Inc. (Neozyme), a subsidiary of International Daleco Corporation , is pleased
to announce its Bio-Organic product, EcoSystem Plus, which had been specified
into an upgrade program for the U.S. Army's Camp Casey in Korea, has recently
received an order for over 2,000 gallons of this highly concentrated
biocatalyst to be used in improving their wastewater facility.

The Company has been successfully working on programs to upgrade wastewater
treatment systems in the United States, and its mission is to improve the
operational efficiencies of water treatment systems worldwide. This program in
Korea is the result of a long-term effort within the global marketplace,
working with partners to bring the Company's advanced Bio-Organic Catalyst
technology to the heavily populated Asian markets where water quality concerns
are creating significant opportunities for cost-effective innovations to a
rapidly developing infrastructure.

Neozyme manufactures and sells its patented line of Bio-Organic Catalytic
formulations for numerous markets including, but not limited to, municipal
wastewater treatment, commercial/industrial, hydrocarbon remediation,
industrial metal cleaning and agriculture.  All Neozyme products are non-toxic,
100% biodegradable and can be safely used around humans, animals, marine life,
vegetation and the environment.  No special clothing or handling apparatus is
required.  For more information, please visit http://www.neozyme.com/.

This News Release contains certain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934.  These forward-looking statements are based
largely on the Company's expectations of forecasts of future events, can be
affected by inaccurate assumptions and are subject to various risks and known
and unknown uncertainties, a number of which are beyond the Company's control.
Therefore, actual results could differ materially from the forward-looking
statements herein. 

DATASOURCE: International Daleco Corporation



CONTACT:  Parker Dale, Chairman of International Daleco Corporation,

[phone], or fax, [phone], 



Web site:  http://www.neozyme.com/ 

Copyright